Tripoint Drug Patent Portfolio
Tripoint owns 1 orange book drug protected by 5 US patents Given below is the list of Tripoint's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8431156 | Pharmaceutical composition | 31 Oct, 2027 | Active |
| US8470367 | Oral drug delivery system | 31 Oct, 2027 | Active |
| US8163306 | Oral drug delivery system | 03 Sep, 2027 | Active |
| US8425938 | Pharmaceutical composition | 22 Feb, 2026 | Active |
| US8535717 | Pharmaceutical composition | 22 Feb, 2026 | Active |
Latest Legal Activities on Tripoint's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Tripoint.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Oct, 2023 | US8163306 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Mar, 2021 | US8535717 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Dec, 2020 | US8470367 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 30 Oct, 2020 | US8431156 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 23 Oct, 2020 | US8425938 |
| Post Issue Communication - Certificate of Correction | 25 Feb, 2020 | US8470367 |
|
Email Notification
Critical
| 19 Oct, 2019 | US8470367 |
| Filing Receipt - Corrected | 18 Oct, 2019 | US8470367 |
| Mail-Petition Decision - Granted | 18 Oct, 2019 | US8470367 |
|
Email Notification
Critical
| 18 Oct, 2019 | US8470367 |
|
Petition Decision - Granted
Critical
| 17 Oct, 2019 | US8470367 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Jul, 2019 | US8163306 |
| Petition Entered | 09 May, 2019 | US8470367 |
| Post Issue Communication - Certificate of Correction | 30 Apr, 2014 | US8470367 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 17 Sep, 2013 | US8535717 |
Tripoint's Family Patents
Tripoint Drug List
Given below is the complete list of Tripoint's drugs and the patents protecting them.
1. Elepsia Xr
Elepsia Xr is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8431156 | Pharmaceutical composition |
31 Oct, 2027
(2 years from now)
| Active |
| US8470367 | Oral drug delivery system |
31 Oct, 2027
(2 years from now)
| Active |
| US8163306 | Oral drug delivery system |
03 Sep, 2027
(1 year, 10 months from now)
| Active |
| US8425938 | Pharmaceutical composition |
22 Feb, 2026
(3 months from now)
| Active |
| US8535717 | Pharmaceutical composition |
22 Feb, 2026
(3 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Elepsia Xr's drug page